A detailed history of Clifford Swan Investment Counsel LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Clifford Swan Investment Counsel LLC holds 79,499 shares of MRK stock, worth $10.1 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
79,499
Previous 83,211 4.46%
Holding current value
$10.1 Million
Previous $9.07 Million 15.63%
% of portfolio
0.39%
Previous 0.35%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$113.24 - $131.95 $420,346 - $489,798
-3,712 Reduced 4.46%
79,499 $10.5 Million
Q4 2023

Feb 06, 2024

BUY
$100.18 - $109.02 $13,624 - $14,826
136 Added 0.16%
83,211 $9.07 Million
Q3 2023

Nov 09, 2023

SELL
$102.95 - $114.33 $90,184 - $100,153
-876 Reduced 1.04%
83,075 $8.55 Million
Q2 2023

Aug 03, 2023

SELL
$108.61 - $118.38 $59,735 - $65,109
-550 Reduced 0.65%
83,951 $9.69 Million
Q1 2023

May 05, 2023

SELL
$102.94 - $114.86 $2,161 - $2,412
-21 Reduced 0.02%
84,501 $8.99 Million
Q4 2022

Feb 02, 2023

SELL
$87.44 - $112.11 $63,918 - $81,952
-731 Reduced 0.86%
84,522 $9.38 Million
Q2 2022

Aug 04, 2022

BUY
$83.49 - $94.64 $31,559 - $35,773
378 Added 0.45%
85,253 $7.77 Million
Q1 2022

May 03, 2022

SELL
$73.51 - $82.4 $31,021 - $34,772
-422 Reduced 0.49%
84,875 $6.96 Million
Q4 2021

Feb 11, 2022

SELL
$72.28 - $90.54 $34,260 - $42,915
-474 Reduced 0.55%
85,297 $6.54 Million
Q3 2021

Nov 02, 2021

BUY
$71.68 - $78.83 $7,168 - $7,883
100 Added 0.12%
85,771 $6.44 Million
Q2 2021

Aug 05, 2021

SELL
$70.31 - $77.77 $21,093 - $23,331
-300 Reduced 0.35%
85,671 $6.47 Million
Q1 2021

May 07, 2021

BUY
$68.86 - $81.11 $6,197 - $7,299
90 Added 0.1%
85,971 $6.63 Million
Q4 2020

Feb 11, 2021

SELL
$71.77 - $79.65 $164,927 - $183,035
-2,298 Reduced 2.61%
85,881 $7.03 Million
Q3 2020

Oct 30, 2020

SELL
$73.18 - $82.95 $98,573 - $111,733
-1,347 Reduced 1.5%
88,179 $7.31 Million
Q2 2020

Aug 06, 2020

SELL
$70.42 - $80.13 $633 - $721
-9 Reduced 0.01%
89,526 $6.92 Million
Q1 2020

Apr 09, 2020

SELL
$63.36 - $87.82 $11,404 - $15,807
-180 Reduced 0.2%
89,535 $6.89 Million
Q4 2019

Jan 30, 2020

SELL
$77.58 - $87.54 $59,193 - $66,793
-763 Reduced 0.84%
89,715 $8.16 Million
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $35,453 - $38,645
466 Added 0.52%
90,478 $7.62 Million
Q2 2019

Aug 13, 2019

SELL
$69.84 - $81.59 $44,627 - $52,136
-639 Reduced 0.7%
90,012 $7.55 Million
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $34,790 - $39,680
-500 Reduced 0.55%
90,651 $7.54 Million
Q4 2018

Feb 13, 2019

SELL
$65.24 - $75.71 $68,502 - $79,495
-1,050 Reduced 1.14%
91,151 $6.97 Million
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $84,919 - $99,860
-1,472 Reduced 1.57%
92,201 $6.54 Million
Q2 2018

Aug 13, 2018

BUY
$50.83 - $59.72 $7,776 - $9,137
153 Added 0.16%
93,673 $5.69 Million
Q1 2018

May 09, 2018

SELL
$50.96 - $59.23 $40,768 - $47,384
-800 Reduced 0.85%
93,520 $5.09 Million
Q4 2017

Feb 09, 2018

BUY
$51.62 - $61.64 $1.42 Million - $1.7 Million
27,544 Added 41.25%
94,320 $5.31 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $19,771 - $21,274
337 Added 0.51%
66,776 $4.28 Million
Q2 2017

Aug 11, 2017

BUY
N/A
66,439
66,439 $4.26 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $320B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Clifford Swan Investment Counsel LLC Portfolio

Follow Clifford Swan Investment Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clifford Swan Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clifford Swan Investment Counsel LLC with notifications on news.